Related Experiment Videos
Truncated WT1 mutants alter the subnuclear localization of the wild-type protein
C Englert1, M Vidal, S Maheswaran
1Massachusetts General Hospital Cancer Center, Charlestown, USA.
Abstract:
WT1 encodes a zinc-finger protein, expressed as distinct isoforms, that is inactivated in a subset of Wilms tumors. Both constitutional and somatic mutations disrupting the DNA-binding domain of WT1 result in a potentially dominant-negative phenotype. In generating inducible cell lines expressing wild-type isoforms of WT1 and WT1 mutants, we observed dramatic differences in the subnuclear localization of the induced proteins. The WT1 isoform that binds with high affinity to a defined DNA target, WT1(-KTS), was diffusely localized throughout the nucleus. In contrast, expression of an alternative splicing variant with reduced DNA binding affinity, WT1 (+KTS), or WT1 mutants with a disrupted zinc-finger domain resulted in a speckled pattern of expression within the nucleus. Although similar in appearance, the localization of WT1 variants to subnuclear clusters was clearly distinct from that of the essential splicing factor SC35, suggesting that WT1 is not directly involved in pre-mRNA splicing. Localization to subnuclear clusters required the N terminus of WT1, and coexpression of a truncated WT1 mutant and wild-type WT1(-KTS) resulted in their physical association, the redistribution of WT1(-KTS) from a diffuse to a speckled pattern, and the inhibition of its transactivational activity. These observations suggest that different WT1 isoforms and WT1 mutants have distinct subnuclear compartments. Dominant-negative WT1 proteins physically associate with wild-type WT1 in vivo and may result in its sequestration within subnuclear structures.
Insights
WT1 protein isoforms and mutants show distinct nuclear localizations, impacting Wilms tumor development. Dominant-negative WT1 variants sequester wild-type WT1, inhibiting its function and suggesting novel therapeutic targets.
Area of Science:
- Molecular Biology
- Cell Biology
- Cancer Research
Background:
- WT1 encodes a zinc-finger protein crucial in development, with mutations linked to Wilms tumors.
- Distinct WT1 isoforms arise from alternative splicing and mutations, affecting DNA-binding and function.
- Disrupted WT1 is implicated in a subset of Wilms tumors, suggesting a dominant-negative effect.
Purpose of the Study:
- To investigate the subnuclear localization of different WT1 isoforms and mutants.
- To determine the functional consequences of altered WT1 localization.
- To elucidate the mechanism of dominant-negative WT1 activity in Wilms tumors.
Main Methods:
- Generation of inducible cell lines expressing wild-type WT1 isoforms and mutants.
- Analysis of subnuclear protein localization using microscopy.
- Co-expression studies to assess protein interactions and functional inhibition.
Main Results:
- WT1(-KTS) localized diffusely, while WT1(+KTS) and WT1 mutants showed speckled nuclear patterns.
- WT1 localization to clusters was distinct from splicing factor SC35, indicating no direct role in splicing.
- N-terminal domain is required for WT1 cluster localization; dominant-negative mutants sequester wild-type WT1, inhibiting its activity.
Conclusions:
- Different WT1 isoforms and mutants exhibit distinct subnuclear compartmentalization.
- Dominant-negative WT1 proteins physically associate with wild-type WT1 in vivo.
- WT1 sequestration in subnuclear structures may underlie its dominant-negative phenotype in Wilms tumors.